XM does not provide services to residents of the United States of America.

Germany to donate 100,000 mpox vaccine doses to combat outbreak in Africa



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 1-Germany to donate 100,000 mpox vaccine doses to combat outbreak in Africa</title></head><body>

Adds details in paragraphs 2-4, 6

BERLIN, Aug 26 (Reuters) -Germany will donate 100,000 mpox vaccine doses from its military stocks to help contain the outbreak on the African continent in the short term as well as provide help to the affected countries, said a government spokesperson on Monday.

The government will provide the World Health Organization with flexible financial resources via various instruments to combat mpox and also support its partners in Africa through the GAVI vaccination alliance, added the spokesperson.

Germany has around 117,000 doses of Jynneos, which is being stockpiled by the German army after Berlin procured it in 2022.

It will keep a minimum amount of stock, to protect travelling authorities, for example, said a defence ministry spokesperson on Monday. A separate decision would need to be made when it comes to reordering vaccines, he added.

The World Health Organization has declared mpox a global public health emergency after an outbreak in the Democratic Republic of the Congo spread to neighbouring countries and a new form of the virus, clade Ib, triggered concerns about the speed of transmission.

The government was looking at the quickest way to get the vaccines to the affected countries, primarily the Democratic Republic of Congo, but also Burundi and neighbouring countries in East Africa, according to a foreign ministry spokesperson.



Reporting by Miranda Murray, editing by Thomas Seythal

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.